Chip Price

Chip Price is a seasoned professional in the pharmaceutical industry, currently serving as a Biosimilar Portfolio Representative at Pfizer since October 2016. In this role, Chip successfully launched the first biosimilars in Rheumatology and two oncology biosimilars, focusing on educating the healthcare industry about their structure and functionality. Prior to Pfizer, Chip worked as a Specialty Sales Representative at Fidia Pharmaceuticals USA, where responsibilities included promoting Hyalgan in multiple states under a "buy and bill" sales model. Chip's earlier experience as a Medical Sales Representative at Eisai Pharmaceuticals involved targeting internal medicine physicians, gastroenterologists, and neurologists, achieving consistent growth in a competitive environment. Chip holds a Master’s degree in Marriage and Family Therapy/Counseling from New Orleans Seminary and a Master’s degree in Clinical, Counseling, and Applied Psychology from Mississippi College.